Atypical Hemolytic Uremic Syndrome (aHUS) Completed Phase Trials for Eculizumab (DB01257)
Also known as: Atypical Hemolytic Uraemic Syndrome / Atypical Hemolytic-Uremic Syndrome / Atypical Hemolytic Uremic Syndrome / Hemolytic-Uremic Syndrome, Atypical / Hemolytic Uremic Syndrome, Atypical / Atypical hemolytic uremic syndrome (disorder) / Atypical haemolytic uraemic syndrome / AHUS
| Indication | Status | Phase |
|---|---|---|
| DBCOND0061539 (Atypical Hemolytic Uremic Syndrome (aHUS)) | Completed | Not Available |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04749810 | Observational Study of Elizaria® in aHUS Patients |